Anthera to Report Second Quarter 2012 Financial Results
HAYWARD, Calif., Aug. 1, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced it will report its unaudited financial results for the second quarter ended June 30, 2012 on Tuesday, August 7, 2012, after the market closes in the United States.
About Anthera Pharmaceuticals
Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation and autoimmune diseases.
SOURCE Anthera Pharmaceuticals, Inc.
More by this Source
Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
May 13, 2013, 17:23 ET
Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study
May 07, 2013, 16:30 ET
Anthera Announces First Quarter 2013 Financial Report and Conference Call
May 03, 2013, 14:06 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.